Skip to main content
Division of Cancer Prevention
Search
Making cancer prevention possible
Home
Major Programs
Major Programs
Cancer Immunoprevention Network (CIP-Net)
Cancer Prevention Clinical Trials Network (CP-CTNet)
Cancer Prevention Fellowship Program (CPFP)
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
Cancer Screening Research Network (CSRN)
Cancer Treatment Tolerability Consortium
Consortium for Imaging and Biomarkers (CIB)
Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP)
Early Detection Research Network (EDRN)
HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
Liquid Biopsy Consortium
Lung Cancer Screening Image Library
NCI Cervical Cancer ‘Last Mile’ Initiative
NCI Community Oncology Research Program (NCORP)
Pancreatic Cancer Detection Consortium (PCDC)
Pre-Cancer Atlas (PCA)
PREVENT Cancer Preclinical Drug Development Program (PREVENT)
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
Supportive Care and Symptom Management
Translational and Basic Science Research in Early Lesions (TBEL) Program
Translational Liver Cancer (TLC) Consortium
US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
Clinical Trials
Clinical Trials
Clinical Trials Search
Clinical Trials Management
Funding & Grants
Funding & Grants
Funding Opportunities
Funded Grants
Grantsmanship Resources
Workforce Initiatives
Tools & Resources
Tools & Resources
Cancer Data Access System (CDAS)
Measurement Error
NCI Resources for Cancer Immunoprevention Research
Publication Search
News & Events
News & Events
News
Blog
DCP Updates
Meetings and Events
Videos and Webinars
Infographics
About DCP
About DCP
DCP Leadership
Organization
Staff Directory
History and Timeline
Home
News & Events
News
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted
Friday, December 22, 2023
, by Linda Wang